Amgen Inc

Company Profile

Amgen Inc had its IPO on 1983-06-17 under the ticker symbol AMGN.

The company operates in the Healthcare sector and Drug Manufacturers-General industry. Amgen Inc has a staff strength of 25,200 employees.

Stock update

Shares of Amgen Inc opened at $233.57 at the start of the last trading session i.e. 2023-03-19.

The stocks traded within a range of $228.52 - $233.81, and closed at $229.79.

This is a -2.04% slip from the previous day's closing price.

A total volume of 7,817,000 shares were traded at the close of the day’s session.

In the last one week, shares of Amgen Inc have increased by +1.77%.

Amgen Inc's Key Ratios

Amgen Inc has a market cap of $122.13 billion, indicating a price to book ratio of 39.6029 and a price to sales ratio of 5.4945.

In the last 12-months Amgen Inc’s revenue was $26.32 billion with a gross profit of $19.92 billion and an EBITDA of $13.49 billion. The EBITDA ratio measures Amgen Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Amgen Inc’s operating margin was 38.25% while its return on assets stood at 9.97% with a return of equity of 126.47%.

In Q4, Amgen Inc’s quarterly earnings growth was a negative -10.9% while revenue growth was a negative 0.1%.

Amgen Inc’s PE and PEG Ratio

Forward PE

14.9477

Trailing PE

18.9025

PEG

1.5503

Its diluted EPS in the last 12-months stands at $12.1 per share while it has a forward price to earnings multiple of 14.9477 and a PEG multiple of 1.5503. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Amgen Inc’s profitability.

Amgen Inc stock is trading at a EV to sales ratio of 6.5285 and a EV to EBITDA ratio of 13.848. Its price to sales ratio in the trailing 12-months stood at 5.4945.

Amgen Inc stock pays annual dividends of $7.76 per share, indicating a yield of 3.73% and a payout ratio of 44.94%.

Balance sheet and cash flow metrics

Total Assets

$65.12 billion

Total Liabilities

$15.69 billion

Operating Cash Flow

$-3473000000.00

Capital Expenditure

$340 million

Dividend Payout Ratio

44.94%

Amgen Inc ended 2023 with $65.12 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $65.12 billion while shareholder equity stood at $3.66 billion.

Amgen Inc ended 2023 with $0 in deferred long-term liabilities, $15.69 billion in other current liabilities, 32514000000.00 in common stock, $-18048000000.00 in retained earnings and $15.53 billion in goodwill. Its cash balance stood at $7.63 billion and cash and short-term investments were $9.31 billion. The company’s total short-term debt was $1,591,000,000 while long-term debt stood at $37.35 billion.

Amgen Inc’s total current assets stands at $22.19 billion while long-term investments were $0 and short-term investments were $1.68 billion. Its net receivables were $5.56 billion compared to accounts payable of $1.57 billion and inventory worth $4.93 billion.

In 2023, Amgen Inc's operating cash flow was $-3473000000.00 while its capital expenditure stood at $340 million.

Comparatively, Amgen Inc paid $0.45 in dividends in 2023.

Other key metrics

Current Trading Price

$229.79

52-Week High

$292.065

52-Week Low

$219.1046

Analyst Target Price

$258.76

Amgen Inc stock is currently trading at $229.79 per share. It touched a 52-week high of $292.065 and a 52-week low of $292.065. Analysts tracking the stock have a 12-month average target price of $258.76.

Its 50-day moving average was $245.29 and 200-day moving average was $248.26 The short ratio stood at 2.81 indicating a short percent outstanding of 0%.

Around 20.9% of the company’s stock are held by insiders while 7993.9% are held by institutions.